648 research outputs found

    Specifying and verifying sensor networks: An experiment of formal methods

    Get PDF
    10.1007/978-3-540-88194-0-20Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)5256 LNCS318-33

    Effect of Acorus tatarinowii extract on hyperprolactinemia in rats

    Get PDF
    Purpose: To determine the mechanism underlying the anti-hyperprolactinemia effect of Acorus tatarinowii extract (ATE) in rats. Methods: Rats were divided into six groups (n =10 each group), viz, healthy control, untreated hyperprolactinemic rats, hyperprolactinemic rats treated with bromocriptine (0.6 mg/kg), and hyperprolactinemic rats treated with ATE (3.2, 6.4, or 12.8 g/kg). After 30 days, the hypothalamic protein levels of dopamine D2 receptor, protein kinase A (PKA), and cyclic adenosine monophosphate (cAMP) were determined. Results: Dopamine D2 receptor levels were lower in untreated hyperprolactinemic rats than in healthy control (p < 0.01), but this decrease was attenuated by ATE (p < 0.05). Elevated PKA levels in untreated hyperprolactinemic rats (0.78 ± 0.03µg/mL, p < 0.01) were decreased by ATE (3.2 g/kg, 0.51 ± 0.02 µg/mL, p < 0.05; 6.4 g/kg, 0.39 ± 0.03 µg/mL, p < 0.01; 12.8 g/kg, 0.24 ± 0.04 µg/mL, p < 0.01). Similarly, elevated cAMP levels in hyperprolactinemic rats (3.1 ± 0.3 ng/mL) were lowered by ATE (3.2 g/kg, 2.2 ± 0.4 ng/mL, p < 0.05; 6.4 g/kg, 1.8 ± 0.3 ng/mL, p < 0.01; 12.8 g/kg, 1.4 ± 0.3 ng/mL, p < 0.01). Conclusion: ATE anti-hyperprolactinemia activity is mediated by dopamine D2 receptor signaling via cAMP/PKA pathway
    corecore